Highlights on patterns of relapse in non-small cell lung cancer to atezolizumab vs best supportive care after adjuvant chemotherapy: IMpower010
ESMO 2021: IMpower010 Study
Share.
About Author
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
